Evidence map›Paper›PMID 38429301›Full record

ArticleCell death & disease2024

BCL-X

Laura J Jenkins, Ian Y Luk, Fiona Chionh, Tao Tan, Kristen Needham, Jamieson Ayton, Camilla M Reehorst, Natalia Vukelic, Oliver M Sieber, Dmitri Mouradov and 10 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Laura J JenkinsOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
Ian Y LukOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
Fiona ChionhOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
Tao TanPersonalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Kristen NeedhamOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
Jamieson AytonOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
Camilla M ReehorstOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
Natalia VukelicOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
Oliver M SieberPersonalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Dmitri MouradovPersonalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Peter GibbsPersonalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
David S WilliamsOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
Niall C TebbuttOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
Jayesh DesaiPeter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0003-4246-9344
Frédéric HollandeDepartment of Clinical Pathology, The University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0002-7046-8392
Amardeep S DhillonThe institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
Erinna F LeeOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
Delphine MerinoOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.ORCID 0000-0002-8075-6275
W Douglas FairlieOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.ORCID 0000-0002-2498-1160
John M MariadasonOlivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia. john.mariadason@onjcri.org.au.ORCID 0000-0001-9123-7684
La Trobe University · AUThe University of Melbourne · AUDeakin University · AUPeter MacCallum Cancer Centre · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

Department of Health | National Health and Medical Research Council (NHMRC) 1046092Department of Health | National Health and Medical Research Council (NHMRC) 1136119Victorian Cancer Agency (VCA) ECRF21035Victorian Cancer Agency (VCA) MCR19045
6 · The paper itself

Abstract

Metastatic BRAF

Indexed as

Antineoplastic AgentsApoptosisbcl-X ProteinCarbamatesColorectal NeoplasmsProtein Kinase InhibitorsAnimalsHumansMiceMyeloid Cell Leukemia Sequence 1 ProteinPiperazinesProto-Oncogene Proteins B-rafSulfonamidesAntineoplastic Agentsbcl-X ProteinBRAF protein, humanCarbamatesDT2216encorafenibMyeloid Cell Leukemia Sequence 1 ProteinPiperazinesProtein Kinase InhibitorsProto-Oncogene Proteins B-rafSulfonamides

Identifiers

PMID38429301
PMCPMC10907349
OpenAlexW4392359851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.